A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort
- PMID: 12944421
- DOI: 10.1093/hmg/ddg294
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort
Abstract
The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the final step of estrogen biosynthesis. Apart from rare mutations in CYP19 which result in severe phenotypes associated with estrogen insufficiency, little is known about whether common variation in CYP19 is associated with risk of hormone-related diseases. In this study, we employed a haplotype-based approach to search for common disease-associated variants in this candidate breast cancer susceptibility gene among African-American, Hawaiian, Japanese, Latina and White women in the Multiethnic Cohort Study (MEC). We utilized 74 densely spaced single-nucleotide polymorphisms (SNPs) (one every approximately 2.6 kb) spanning 189.4 kb of the CYP19 locus to characterize linkage disequilibrium (LD) and haplotype patterns among 69-70 individuals from each ethnic population. We detected four regions of strong LD (blocks 1-4) that were quite closely conserved across populations. Within each block there was a limited diversity of common haplotypes (5 to 10 with a frequency >/=5%) and most haplotypes were observed to be shared across populations. Twenty-five haplotype-tagging SNPs (htSNPs) were selected to predict the common haplotypes with high probability (average Rh2=0.92) and genotyped in a breast cancer case-control study in the MEC (cases, n=1355; controls, n=2580). We first performed global tests for differences in risk according to the common haplotypes and observed significant haplotype-effects in block 2 [P=0.01; haplotypes 2b (OR=1.23; 95% CI, 1.07-1.40), 2d (OR=1.28; 95% CI, 1.01-1.62)]. We also found a common long-range haplotype comprised of block-specific haplotypes 2b and 3c to be associated with increased risk of breast cancer (haplotype 2b-3c: OR=1.31; 95% CI, 1.11-1.54). Our findings suggest the hypothesis that women with the long-range CYP19 haplotype 2b-3c may be carriers of a predisposing breast cancer susceptibility allele.
Similar articles
-
Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1021-5. doi: 10.1158/1055-9965.EPI-05-0896. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702386
-
Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.Hum Mol Genet. 2004 Oct 15;13(20):2431-41. doi: 10.1093/hmg/ddh270. Epub 2004 Aug 18. Hum Mol Genet. 2004. PMID: 15317758
-
A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.Cancer Res. 2006 Dec 15;66(24):12019-25. doi: 10.1158/0008-5472.CAN-06-1101. Cancer Res. 2006. PMID: 17178901
-
Haplotypes and the systematic analysis of genetic variation in genes and genomes.Pharmacogenomics. 2003 Sep;4(5):547-70. doi: 10.2217/14622416.4.5.547. Pharmacogenomics. 2003. PMID: 12943464 Review.
-
On the applicability of a haplotype map to un-assayed populations.Hum Genet. 2004 Jan;114(2):214-7. doi: 10.1007/s00439-003-1046-x. Epub 2003 Oct 25. Hum Genet. 2004. PMID: 14579151 Review.
Cited by
-
Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females.Hum Mol Genet. 2006 Aug 15;15(16):2401-8. doi: 10.1093/hmg/ddl155. Epub 2006 Jun 16. Hum Mol Genet. 2006. PMID: 16782804 Free PMC article.
-
Snagger: a user-friendly program for incorporating additional information for tagSNP selection.BMC Bioinformatics. 2008 Mar 27;9:174. doi: 10.1186/1471-2105-9-174. BMC Bioinformatics. 2008. PMID: 18371222 Free PMC article.
-
Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.Cancer Causes Control. 2014 Nov;25(11):1461-71. doi: 10.1007/s10552-014-0448-5. Epub 2014 Aug 5. Cancer Causes Control. 2014. PMID: 25088806 Free PMC article.
-
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7. doi: 10.1158/1055-9965.EPI-08-0689. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124504 Free PMC article.
-
Genetic Determinants of Circulating Estrogen Levels and Evidence of a Causal Effect of Estradiol on Bone Density in Men.J Clin Endocrinol Metab. 2018 Mar 1;103(3):991-1004. doi: 10.1210/jc.2017-02060. J Clin Endocrinol Metab. 2018. PMID: 29325096 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials